Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects

Immune dysregulation, specifically of inflammatory processes, has been linked to behavioral symptoms of depression in both human and rodent studies. Here, we evaluated the antidepressant effects of immunization with altered peptide ligands of myelin basic protein (MBP)—MBP 87–99 [A 91 , A 96 ], MBP...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry 2020-06, Vol.25 (6), p.1260-1274
Hauptverfasser: Han, Ying, Sun, Cheng-Yu, Meng, Shi-Qiu, Tabarak, Serik, Yuan, Kai, Cao, Lu, Yan, Wei, Xu, Ling-Zhi, Deng, Jia-Hui, Zhu, Wei-Li, Li, Jia-Li, Lu, Lin, Xue, Yan-Xue, Shi, Jie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1274
container_issue 6
container_start_page 1260
container_title Molecular psychiatry
container_volume 25
creator Han, Ying
Sun, Cheng-Yu
Meng, Shi-Qiu
Tabarak, Serik
Yuan, Kai
Cao, Lu
Yan, Wei
Xu, Ling-Zhi
Deng, Jia-Hui
Zhu, Wei-Li
Li, Jia-Li
Lu, Lin
Xue, Yan-Xue
Shi, Jie
description Immune dysregulation, specifically of inflammatory processes, has been linked to behavioral symptoms of depression in both human and rodent studies. Here, we evaluated the antidepressant effects of immunization with altered peptide ligands of myelin basic protein (MBP)—MBP 87–99 [A 91 , A 96 ], MBP 87–99 [A 91 ], and MBP 87–99 [R 91 , A 96 ]—in different models of depression and examined the mechanism by which these peptides protect against stress-induced depression. We found that a single dose of subcutaneously administered MBP 87–99 [A 91 , A 96 ] produced antidepressant-like effects by decreasing immobility in the forced swim test and by reducing the escape latency and escape failures in the learned helplessness paradigm. Moreover, immunization with MBP 87–99 [A 91 , A 96 ] prevented and reversed depressive-like and anxiety-like behaviors that were induced by chronic unpredictable stress (CUS). However, MBP 87–99 [R 91 , A 96 ] tended to aggravate CUS-induced anxiety-like behavior. Chronic stress increased the production of peripheral and central proinflammatory cytokines and induced the activation of microglia in the prelimbic cortex (PrL), which was blocked by MBP 87–99 [A 91 , A 96 ]. Immunization with MBP-derived altered peptide ligands also rescued chronic stress-induced deficits in p11, phosphorylated cyclic adenosine monophosphate response element binding protein, and brain-derived neurotrophic factor expression. Moreover, microinjections of recombinant proinflammatory cytokines and the knockdown of p11 in the PrL blunted the antidepressant-like behavioral response to MBP 87–99 [A 91 , A 96 ]. Altogether, these findings indicate that immunization with altered MBP peptide produces prolonged antidepressant-like effects in rats, and the behavioral response is mediated by inflammatory factors (particularly interleukin-6), and p11 signaling in the PrL. Immune–neural interactions may impact central nervous system function and alter an individual’s response to stress.
doi_str_mv 10.1038/s41380-019-0470-9
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2476734935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A624705182</galeid><sourcerecordid>A624705182</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-70b5eb0a606cbdc8eb3e10737f48ec3147d9589ca81e6b176f144f17c05e6c1e3</originalsourceid><addsrcrecordid>eNp9kU1vFiEQx4nR2NcP4MVs4pkKD7Cwx6bxLWniofVMWHao1F12ZdiYp59eNk-1MVHDgRnmN8PM_Al5xdkFZ8K8RcmFYZTxjjKpGe2ekWMudUuV0uZ5tYXqqORGHpETxHvGtqB6SY4EF1pp3R2TdLPHAlP0TZymNcUHV-Kcmh-xfG3cWCDD0Ex7GGNqeocVW_JcoHoLLCUOsPnD6gEbXLG4mCrv0hZZMiBWk47xGzQQAviCZ-RFcCPC-eN9Sr68f3d79ZFef_7w6erymnrZ6kI16xX0zLWs9f3gDfQCONNCB2nAizrG0CnTeWc4tD3XbeBSBq49U9B6DuKUvDnUre19XwGLvZ_XnOqXdld3oIXshPo_xZSRbMe7J-rOjWBjCnPJzk8Rvb1sazWmuNlV6uIvVD3Dtt05QYj1_Y8EfkjweUbMEOyS4-Ty3nJmN3ntQV5b5bWbvHZr5fVjw2s_wfA745eeFdgdAKyhdAf5aaJ_V_0JH62wAg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2405840219</pqid></control><display><type>article</type><title>Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Han, Ying ; Sun, Cheng-Yu ; Meng, Shi-Qiu ; Tabarak, Serik ; Yuan, Kai ; Cao, Lu ; Yan, Wei ; Xu, Ling-Zhi ; Deng, Jia-Hui ; Zhu, Wei-Li ; Li, Jia-Li ; Lu, Lin ; Xue, Yan-Xue ; Shi, Jie</creator><creatorcontrib>Han, Ying ; Sun, Cheng-Yu ; Meng, Shi-Qiu ; Tabarak, Serik ; Yuan, Kai ; Cao, Lu ; Yan, Wei ; Xu, Ling-Zhi ; Deng, Jia-Hui ; Zhu, Wei-Li ; Li, Jia-Li ; Lu, Lin ; Xue, Yan-Xue ; Shi, Jie</creatorcontrib><description>Immune dysregulation, specifically of inflammatory processes, has been linked to behavioral symptoms of depression in both human and rodent studies. Here, we evaluated the antidepressant effects of immunization with altered peptide ligands of myelin basic protein (MBP)—MBP 87–99 [A 91 , A 96 ], MBP 87–99 [A 91 ], and MBP 87–99 [R 91 , A 96 ]—in different models of depression and examined the mechanism by which these peptides protect against stress-induced depression. We found that a single dose of subcutaneously administered MBP 87–99 [A 91 , A 96 ] produced antidepressant-like effects by decreasing immobility in the forced swim test and by reducing the escape latency and escape failures in the learned helplessness paradigm. Moreover, immunization with MBP 87–99 [A 91 , A 96 ] prevented and reversed depressive-like and anxiety-like behaviors that were induced by chronic unpredictable stress (CUS). However, MBP 87–99 [R 91 , A 96 ] tended to aggravate CUS-induced anxiety-like behavior. Chronic stress increased the production of peripheral and central proinflammatory cytokines and induced the activation of microglia in the prelimbic cortex (PrL), which was blocked by MBP 87–99 [A 91 , A 96 ]. Immunization with MBP-derived altered peptide ligands also rescued chronic stress-induced deficits in p11, phosphorylated cyclic adenosine monophosphate response element binding protein, and brain-derived neurotrophic factor expression. Moreover, microinjections of recombinant proinflammatory cytokines and the knockdown of p11 in the PrL blunted the antidepressant-like behavioral response to MBP 87–99 [A 91 , A 96 ]. Altogether, these findings indicate that immunization with altered MBP peptide produces prolonged antidepressant-like effects in rats, and the behavioral response is mediated by inflammatory factors (particularly interleukin-6), and p11 signaling in the PrL. Immune–neural interactions may impact central nervous system function and alter an individual’s response to stress.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/s41380-019-0470-9</identifier><identifier>PMID: 31375779</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/51 ; 42/44 ; 631/337 ; 692/699/476/1414 ; 82/80 ; 96/21 ; Analysis ; Animals ; Antidepressants ; Antidepressive Agents - chemistry ; Antidepressive Agents - immunology ; Antidepressive Agents - therapeutic use ; Anxiety ; Anxiety - drug therapy ; Anxiety - etiology ; Anxiety - immunology ; Behavioral Sciences ; Biological Psychology ; Brain-derived neurotrophic factor ; Brain-Derived Neurotrophic Factor - metabolism ; Central nervous system ; Cyclic AMP ; Cytokines ; Depression - drug therapy ; Depression - etiology ; Depression - immunology ; Depression - therapy ; Depression, Mental ; Disease Models, Animal ; Immunization ; Inflammation ; Interleukin 6 ; Latency ; Learned helplessness ; Ligands ; Medicine ; Medicine &amp; Public Health ; Mental depression ; Microglia ; Myelin ; Myelin basic protein ; Myelin Basic Protein - administration &amp; dosage ; Myelin Basic Protein - chemistry ; Myelin Basic Protein - immunology ; Myelin Basic Protein - therapeutic use ; Myelin proteins ; Neurosciences ; Peptides ; Pharmacotherapy ; Protein binding ; Proteins ; Psychiatry ; Rats ; Stress ; Stress (Psychology) ; Stress, Psychological - complications ; Stress, Psychological - drug therapy ; Stress, Psychological - immunology</subject><ispartof>Molecular psychiatry, 2020-06, Vol.25 (6), p.1260-1274</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2019</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2019.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-70b5eb0a606cbdc8eb3e10737f48ec3147d9589ca81e6b176f144f17c05e6c1e3</citedby><cites>FETCH-LOGICAL-c467t-70b5eb0a606cbdc8eb3e10737f48ec3147d9589ca81e6b176f144f17c05e6c1e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31375779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Han, Ying</creatorcontrib><creatorcontrib>Sun, Cheng-Yu</creatorcontrib><creatorcontrib>Meng, Shi-Qiu</creatorcontrib><creatorcontrib>Tabarak, Serik</creatorcontrib><creatorcontrib>Yuan, Kai</creatorcontrib><creatorcontrib>Cao, Lu</creatorcontrib><creatorcontrib>Yan, Wei</creatorcontrib><creatorcontrib>Xu, Ling-Zhi</creatorcontrib><creatorcontrib>Deng, Jia-Hui</creatorcontrib><creatorcontrib>Zhu, Wei-Li</creatorcontrib><creatorcontrib>Li, Jia-Li</creatorcontrib><creatorcontrib>Lu, Lin</creatorcontrib><creatorcontrib>Xue, Yan-Xue</creatorcontrib><creatorcontrib>Shi, Jie</creatorcontrib><title>Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><addtitle>Mol Psychiatry</addtitle><description>Immune dysregulation, specifically of inflammatory processes, has been linked to behavioral symptoms of depression in both human and rodent studies. Here, we evaluated the antidepressant effects of immunization with altered peptide ligands of myelin basic protein (MBP)—MBP 87–99 [A 91 , A 96 ], MBP 87–99 [A 91 ], and MBP 87–99 [R 91 , A 96 ]—in different models of depression and examined the mechanism by which these peptides protect against stress-induced depression. We found that a single dose of subcutaneously administered MBP 87–99 [A 91 , A 96 ] produced antidepressant-like effects by decreasing immobility in the forced swim test and by reducing the escape latency and escape failures in the learned helplessness paradigm. Moreover, immunization with MBP 87–99 [A 91 , A 96 ] prevented and reversed depressive-like and anxiety-like behaviors that were induced by chronic unpredictable stress (CUS). However, MBP 87–99 [R 91 , A 96 ] tended to aggravate CUS-induced anxiety-like behavior. Chronic stress increased the production of peripheral and central proinflammatory cytokines and induced the activation of microglia in the prelimbic cortex (PrL), which was blocked by MBP 87–99 [A 91 , A 96 ]. Immunization with MBP-derived altered peptide ligands also rescued chronic stress-induced deficits in p11, phosphorylated cyclic adenosine monophosphate response element binding protein, and brain-derived neurotrophic factor expression. Moreover, microinjections of recombinant proinflammatory cytokines and the knockdown of p11 in the PrL blunted the antidepressant-like behavioral response to MBP 87–99 [A 91 , A 96 ]. Altogether, these findings indicate that immunization with altered MBP peptide produces prolonged antidepressant-like effects in rats, and the behavioral response is mediated by inflammatory factors (particularly interleukin-6), and p11 signaling in the PrL. Immune–neural interactions may impact central nervous system function and alter an individual’s response to stress.</description><subject>13/1</subject><subject>13/51</subject><subject>42/44</subject><subject>631/337</subject><subject>692/699/476/1414</subject><subject>82/80</subject><subject>96/21</subject><subject>Analysis</subject><subject>Animals</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - chemistry</subject><subject>Antidepressive Agents - immunology</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>Anxiety</subject><subject>Anxiety - drug therapy</subject><subject>Anxiety - etiology</subject><subject>Anxiety - immunology</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Brain-derived neurotrophic factor</subject><subject>Brain-Derived Neurotrophic Factor - metabolism</subject><subject>Central nervous system</subject><subject>Cyclic AMP</subject><subject>Cytokines</subject><subject>Depression - drug therapy</subject><subject>Depression - etiology</subject><subject>Depression - immunology</subject><subject>Depression - therapy</subject><subject>Depression, Mental</subject><subject>Disease Models, Animal</subject><subject>Immunization</subject><subject>Inflammation</subject><subject>Interleukin 6</subject><subject>Latency</subject><subject>Learned helplessness</subject><subject>Ligands</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental depression</subject><subject>Microglia</subject><subject>Myelin</subject><subject>Myelin basic protein</subject><subject>Myelin Basic Protein - administration &amp; dosage</subject><subject>Myelin Basic Protein - chemistry</subject><subject>Myelin Basic Protein - immunology</subject><subject>Myelin Basic Protein - therapeutic use</subject><subject>Myelin proteins</subject><subject>Neurosciences</subject><subject>Peptides</subject><subject>Pharmacotherapy</subject><subject>Protein binding</subject><subject>Proteins</subject><subject>Psychiatry</subject><subject>Rats</subject><subject>Stress</subject><subject>Stress (Psychology)</subject><subject>Stress, Psychological - complications</subject><subject>Stress, Psychological - drug therapy</subject><subject>Stress, Psychological - immunology</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kU1vFiEQx4nR2NcP4MVs4pkKD7Cwx6bxLWniofVMWHao1F12ZdiYp59eNk-1MVHDgRnmN8PM_Al5xdkFZ8K8RcmFYZTxjjKpGe2ekWMudUuV0uZ5tYXqqORGHpETxHvGtqB6SY4EF1pp3R2TdLPHAlP0TZymNcUHV-Kcmh-xfG3cWCDD0Ex7GGNqeocVW_JcoHoLLCUOsPnD6gEbXLG4mCrv0hZZMiBWk47xGzQQAviCZ-RFcCPC-eN9Sr68f3d79ZFef_7w6erymnrZ6kI16xX0zLWs9f3gDfQCONNCB2nAizrG0CnTeWc4tD3XbeBSBq49U9B6DuKUvDnUre19XwGLvZ_XnOqXdld3oIXshPo_xZSRbMe7J-rOjWBjCnPJzk8Rvb1sazWmuNlV6uIvVD3Dtt05QYj1_Y8EfkjweUbMEOyS4-Ty3nJmN3ntQV5b5bWbvHZr5fVjw2s_wfA745eeFdgdAKyhdAf5aaJ_V_0JH62wAg</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Han, Ying</creator><creator>Sun, Cheng-Yu</creator><creator>Meng, Shi-Qiu</creator><creator>Tabarak, Serik</creator><creator>Yuan, Kai</creator><creator>Cao, Lu</creator><creator>Yan, Wei</creator><creator>Xu, Ling-Zhi</creator><creator>Deng, Jia-Hui</creator><creator>Zhu, Wei-Li</creator><creator>Li, Jia-Li</creator><creator>Lu, Lin</creator><creator>Xue, Yan-Xue</creator><creator>Shi, Jie</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20200601</creationdate><title>Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects</title><author>Han, Ying ; Sun, Cheng-Yu ; Meng, Shi-Qiu ; Tabarak, Serik ; Yuan, Kai ; Cao, Lu ; Yan, Wei ; Xu, Ling-Zhi ; Deng, Jia-Hui ; Zhu, Wei-Li ; Li, Jia-Li ; Lu, Lin ; Xue, Yan-Xue ; Shi, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-70b5eb0a606cbdc8eb3e10737f48ec3147d9589ca81e6b176f144f17c05e6c1e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>13/1</topic><topic>13/51</topic><topic>42/44</topic><topic>631/337</topic><topic>692/699/476/1414</topic><topic>82/80</topic><topic>96/21</topic><topic>Analysis</topic><topic>Animals</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - chemistry</topic><topic>Antidepressive Agents - immunology</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>Anxiety</topic><topic>Anxiety - drug therapy</topic><topic>Anxiety - etiology</topic><topic>Anxiety - immunology</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Brain-derived neurotrophic factor</topic><topic>Brain-Derived Neurotrophic Factor - metabolism</topic><topic>Central nervous system</topic><topic>Cyclic AMP</topic><topic>Cytokines</topic><topic>Depression - drug therapy</topic><topic>Depression - etiology</topic><topic>Depression - immunology</topic><topic>Depression - therapy</topic><topic>Depression, Mental</topic><topic>Disease Models, Animal</topic><topic>Immunization</topic><topic>Inflammation</topic><topic>Interleukin 6</topic><topic>Latency</topic><topic>Learned helplessness</topic><topic>Ligands</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental depression</topic><topic>Microglia</topic><topic>Myelin</topic><topic>Myelin basic protein</topic><topic>Myelin Basic Protein - administration &amp; dosage</topic><topic>Myelin Basic Protein - chemistry</topic><topic>Myelin Basic Protein - immunology</topic><topic>Myelin Basic Protein - therapeutic use</topic><topic>Myelin proteins</topic><topic>Neurosciences</topic><topic>Peptides</topic><topic>Pharmacotherapy</topic><topic>Protein binding</topic><topic>Proteins</topic><topic>Psychiatry</topic><topic>Rats</topic><topic>Stress</topic><topic>Stress (Psychology)</topic><topic>Stress, Psychological - complications</topic><topic>Stress, Psychological - drug therapy</topic><topic>Stress, Psychological - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Han, Ying</creatorcontrib><creatorcontrib>Sun, Cheng-Yu</creatorcontrib><creatorcontrib>Meng, Shi-Qiu</creatorcontrib><creatorcontrib>Tabarak, Serik</creatorcontrib><creatorcontrib>Yuan, Kai</creatorcontrib><creatorcontrib>Cao, Lu</creatorcontrib><creatorcontrib>Yan, Wei</creatorcontrib><creatorcontrib>Xu, Ling-Zhi</creatorcontrib><creatorcontrib>Deng, Jia-Hui</creatorcontrib><creatorcontrib>Zhu, Wei-Li</creatorcontrib><creatorcontrib>Li, Jia-Li</creatorcontrib><creatorcontrib>Lu, Lin</creatorcontrib><creatorcontrib>Xue, Yan-Xue</creatorcontrib><creatorcontrib>Shi, Jie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Han, Ying</au><au>Sun, Cheng-Yu</au><au>Meng, Shi-Qiu</au><au>Tabarak, Serik</au><au>Yuan, Kai</au><au>Cao, Lu</au><au>Yan, Wei</au><au>Xu, Ling-Zhi</au><au>Deng, Jia-Hui</au><au>Zhu, Wei-Li</au><au>Li, Jia-Li</au><au>Lu, Lin</au><au>Xue, Yan-Xue</au><au>Shi, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><addtitle>Mol Psychiatry</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>25</volume><issue>6</issue><spage>1260</spage><epage>1274</epage><pages>1260-1274</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>Immune dysregulation, specifically of inflammatory processes, has been linked to behavioral symptoms of depression in both human and rodent studies. Here, we evaluated the antidepressant effects of immunization with altered peptide ligands of myelin basic protein (MBP)—MBP 87–99 [A 91 , A 96 ], MBP 87–99 [A 91 ], and MBP 87–99 [R 91 , A 96 ]—in different models of depression and examined the mechanism by which these peptides protect against stress-induced depression. We found that a single dose of subcutaneously administered MBP 87–99 [A 91 , A 96 ] produced antidepressant-like effects by decreasing immobility in the forced swim test and by reducing the escape latency and escape failures in the learned helplessness paradigm. Moreover, immunization with MBP 87–99 [A 91 , A 96 ] prevented and reversed depressive-like and anxiety-like behaviors that were induced by chronic unpredictable stress (CUS). However, MBP 87–99 [R 91 , A 96 ] tended to aggravate CUS-induced anxiety-like behavior. Chronic stress increased the production of peripheral and central proinflammatory cytokines and induced the activation of microglia in the prelimbic cortex (PrL), which was blocked by MBP 87–99 [A 91 , A 96 ]. Immunization with MBP-derived altered peptide ligands also rescued chronic stress-induced deficits in p11, phosphorylated cyclic adenosine monophosphate response element binding protein, and brain-derived neurotrophic factor expression. Moreover, microinjections of recombinant proinflammatory cytokines and the knockdown of p11 in the PrL blunted the antidepressant-like behavioral response to MBP 87–99 [A 91 , A 96 ]. Altogether, these findings indicate that immunization with altered MBP peptide produces prolonged antidepressant-like effects in rats, and the behavioral response is mediated by inflammatory factors (particularly interleukin-6), and p11 signaling in the PrL. Immune–neural interactions may impact central nervous system function and alter an individual’s response to stress.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>31375779</pmid><doi>10.1038/s41380-019-0470-9</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1359-4184
ispartof Molecular psychiatry, 2020-06, Vol.25 (6), p.1260-1274
issn 1359-4184
1476-5578
language eng
recordid cdi_proquest_journals_2476734935
source MEDLINE; Alma/SFX Local Collection
subjects 13/1
13/51
42/44
631/337
692/699/476/1414
82/80
96/21
Analysis
Animals
Antidepressants
Antidepressive Agents - chemistry
Antidepressive Agents - immunology
Antidepressive Agents - therapeutic use
Anxiety
Anxiety - drug therapy
Anxiety - etiology
Anxiety - immunology
Behavioral Sciences
Biological Psychology
Brain-derived neurotrophic factor
Brain-Derived Neurotrophic Factor - metabolism
Central nervous system
Cyclic AMP
Cytokines
Depression - drug therapy
Depression - etiology
Depression - immunology
Depression - therapy
Depression, Mental
Disease Models, Animal
Immunization
Inflammation
Interleukin 6
Latency
Learned helplessness
Ligands
Medicine
Medicine & Public Health
Mental depression
Microglia
Myelin
Myelin basic protein
Myelin Basic Protein - administration & dosage
Myelin Basic Protein - chemistry
Myelin Basic Protein - immunology
Myelin Basic Protein - therapeutic use
Myelin proteins
Neurosciences
Peptides
Pharmacotherapy
Protein binding
Proteins
Psychiatry
Rats
Stress
Stress (Psychology)
Stress, Psychological - complications
Stress, Psychological - drug therapy
Stress, Psychological - immunology
title Systemic immunization with altered myelin basic protein peptide produces sustained antidepressant-like effects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T17%3A42%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20immunization%20with%20altered%20myelin%20basic%20protein%20peptide%20produces%20sustained%20antidepressant-like%20effects&rft.jtitle=Molecular%20psychiatry&rft.au=Han,%20Ying&rft.date=2020-06-01&rft.volume=25&rft.issue=6&rft.spage=1260&rft.epage=1274&rft.pages=1260-1274&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/s41380-019-0470-9&rft_dat=%3Cgale_proqu%3EA624705182%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2405840219&rft_id=info:pmid/31375779&rft_galeid=A624705182&rfr_iscdi=true